Algeria – LNCPP mandate as WHO accredited Pharma QC Laboratory renewed

February 10, 2013 11:45 am0 commentsViews: 345

Prof. Mansouri (Head of LNCPP) inaugurating MAGHREB PHARMA Expo in 2012 in Algiers

The World Health Organization (WHO) has renewed its confidence in the LNCPP (National Laboratory for Control of Pharmaceuticals Products) as a reference laboratory for the Middle East and Africa region, announced yesterday in Algiers, the Head of the laboratory, Prof. Mohamed Mansouri (recently designed as Head of the future Algerian Drug Agency).

WHO will soon announce the renewal of its confidence, for the fourth consecutive time in the LNCPP  for the quality of its services in the control of pharmaceuticals, Professor Mansouri said on the sidelines of the bioequivalence study of “Furosemide” a generic used in the treatment of heart disease, to demonstrate bioequivalence with the originator.

The LNCPP has been trusted by the WHO since 2003. In 2007, thanks to the results of analyzes carried out by experts of the LNCPP, WHO had eight drugs withdrawn from the market that didn’t comply with standards in the production of medicines. The laboratory has established itself globally in the field of control of pharmaceutical products and the fight against counterfeit medicines whose Algerian market is free of, according to Professor Mansouri.


Comment this Post

You must be logged in to post a comment.

Recent Comments